Alignment Healthcare (NASDAQ:ALHC) Trading 10.3% Higher – Here’s What Happened

09 Jun 2026, 17:42 by Mitch Edgeman · The Markets Daily

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report)’s stock price traded up 10.3% on Tuesday . The stock traded as high as $16.87 and last traded at $16.9240. 1,248,266 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 4,012,689 shares. The stock had previously closed at $15.35.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 28th. Barclays cut their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Finally, UBS Group increased their target price on Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $24.30.

View Our Latest Analysis on ALHC

Alignment Healthcare Stock Up 19.6%

The firm has a fifty day simple moving average of $18.31 and a 200-day simple moving average of $19.32. The company has a market capitalization of $3.79 billion, a P/E ratio of 203.16, a P/E/G ratio of 2.08 and a beta of 1.14. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.05) earnings per share. On average, equities research analysts expect that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Insider Buying and Selling

In other Alignment Healthcare news, insider Mark D. Kent acquired 14,848 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was bought at an average cost of $13.31 per share, with a total value of $197,626.88. Following the completion of the transaction, the insider directly owned 14,848 shares in the company, valued at approximately $197,626.88. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO James M. Head sold 11,100 shares of the firm’s stock in a transaction that occurred on Tuesday, April 7th. The shares were sold at an average price of $21.08, for a total value of $233,988.00. Following the completion of the sale, the chief financial officer directly owned 173,495 shares of the company’s stock, valued at approximately $3,657,274.60. The trade was a 6.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 1,368,741 shares of company stock valued at $25,765,741. Insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

A number of large investors have recently made changes to their positions in ALHC. Summit Securities Group LLC bought a new position in shares of Alignment Healthcare during the fourth quarter worth approximately $26,000. Parallel Advisors LLC increased its stake in shares of Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare during the third quarter worth approximately $33,000. First Horizon Corp bought a new position in shares of Alignment Healthcare during the fourth quarter worth approximately $39,000. Finally, GAMMA Investing LLC increased its stake in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares during the period. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.